Find policies, billing codes, payers, states, and providers
Loading...
Find policies, billing codes, payers, states, and providers
HCPCS Level II J0013: Esketamine Nasal Spray, 1 mg
HCPCS-J0120-INJECTION-TETRACYCLINE-250MGHCPCS Level II J0120: Injection, Tetracycline, up to 250 mg
HCPCS-J0121-OMADACYCLINE-INJECTION-1MGHCPCS Level II J0121: Omadacycline Injection, 1 mg
HCPCS-J0122-ERAVACYCLINE-INJECTION-1MGHCPCS Level II J0122: Injection, eravacycline, 1 mg
HCPCS-J0129-ABATACEPT-INJECTION-10MG-PHYSICIAN-SUPERVISEDHCPCS Level II J0129: Abatacept Injection, 10 mg
HCPCS-J0130-INJECTION-ABCIXIMAB-10MGHCPCS Level II J0130: Injection abciximab, 10 mg
HCPCS-J0131-INJECTION-ACETAMINOPHEN-10MG-PARENTERAL-ANALGESICHCPCS Level II J0131: Injection, Acetaminophen 10 mg
HCPCS-J0132-INJECTION-ACETYLCYSTEINE-100MG-INJECTABLE-MEDICATIONHCPCS Level II J0132: Injection, Acetylcysteine 100 mg
HCPCS-J0133-ACYCLOVIR-INJECTION-5MGHCPCS Level II J0133: Injection, Acyclovir 5 mg
HCPCS-J0134-ACETAMINOPHEN-INJECTION-FRESENIUS-KABI-10MGHCPCS Level II J0134: Injection, Acetaminophen (10 mg)
Showing 1–10 of 992
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.